Fasting-mimicking Diet and Immunosenescence
NCT02554188 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2019-10-30
Summary
The objective of this study is to test a Fasting-Mimicking Diet (FMD) for its efficacy on improving immune response to flu vaccination in an older adult population (50-75 years of age).
Conditions
- Immunosenescence
Interventions
- BIOLOGICAL
-
Seasonal influenza (flu) vaccine
Seasonal influenza (flu) vaccine * Fluzone Quadrivalent Vaccine (Sanofi Pasteur), for participants ages 50 - 64 years old * Fluzone High-Dose (Sanofi Pasteur), for participants ages 65 years and older
- OTHER
-
Diet
A 5-day low calorie fasting-mimicking diet
Sponsors & Collaborators
-
University of Southern California
lead OTHER
Principal Investigators
-
Elizabeth Zelinski, PhD · University of Southern California
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-05-01
- Primary Completion
- 2019-05-01
- Completion
- 2019-05-01
More Related Trials
-
Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults
NCT01730144 ·Status: COMPLETED
-
Impact of High Dietary Fiber on Microbiome and Vaccine Responses
NCT05565586 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood
NCT03898973 ·Status: WITHDRAWN ·Phase: PHASE4
-
Cell Mediated Immunity in Older Adults
NCT01189123 ·Status: COMPLETED ·Phase: NA
-
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
NCT02680002 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects
NCT01422512 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Response of Intradermal and Intramuscular Preparations of Inactive Seasonal Influenza Vaccine in Older Age Group.
NCT02101749 ·Status: COMPLETED ·Phase: PHASE4
-
Association Between Gut Microbiome and Dietary Determinants and Vaccine Response
NCT05239403 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
NCT01052480 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity
NCT01896154 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine
NCT00311727 ·Status: COMPLETED ·Phase: NA
-
A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
NCT02251288 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A
NCT02572817 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects
NCT01162122 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Immune Response to Seasonal FluMist in Healthy Adults
NCT01673425 ·Status: TERMINATED ·Phase: NA
-
Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older
NCT02665871 ·Status: UNKNOWN ·Phase: PHASE1
-
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
NCT05215327 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age
NCT02587221 ·Status: COMPLETED ·Phase: PHASE3
-
Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated
NCT05512494 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Age on Response to the 2009 H1N1 Virus Vaccine
NCT01055184 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Systems Investigation of Vaccine Responses in Aging and Frailty
NCT05291676 ·Status: RECRUITING ·Phase: PHASE2
-
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older
NCT00192153 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Influenza Vaccine Evaluation
NCT02872311 ·Status: COMPLETED ·Phase: NA
-
Effect of Blueberries on Immunity
NCT05534893 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine
NCT01201902 ·Status: COMPLETED ·Phase: PHASE3